HF
SGMO

HRT Financial’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

HRT Financial’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-205,170
Closed -$111K – 3580
2025
Q2 		$111K Buy
205,170
+67,902
+49% +$40.3K ﹤0.01% 2191
2025
Q1 		$90K Buy
+137,268
New +$145K ﹤0.01% 2166
2024
Q3 		– Sell
-264,441
Closed -$94K – 3053
2024
Q2 		$94K Buy
+264,441
New +$143K ﹤0.01% 1770
2024
Q1 		– Sell
-72,177
Closed -$39K – 3005
2023
Q4 		$39K Buy
72,177
+20,383
+39% +$9.4K ﹤0.01% 1980
2023
Q3 		$31K Sell
51,794
-690,012
-93% -$739K ﹤0.01% 2036
2023
Q2 		$964K Buy
741,806
+257,655
+53% +$352K 0.01% 974
2023
Q1 		$852K Buy
+484,151
New +$1.38M 0.01% 1033
2022
Q3 		– Sell
-120,316
Closed -$498K – 3428
2022
Q2 		$498K Buy
+120,316
New +$520K 0.01% 1567
2022
Q1 		– Sell
-76,247
Closed -$571K – 3785
2021
Q4 		$571K Buy
76,247
+37,854
+99% +$329K ﹤0.01% 1653
2021
Q3 		$345K Sell
38,393
-45,362
-54% -$448K ﹤0.01% 2320
2021
Q2 		$1M Buy
+83,755
New +$948K 0.01% 1113
2021
Q1 		– Sell
-19,058
Closed -$297K – 3098
2020
Q4 		$297K Buy
19,058
+8,729
+85% +$102K 0.01% 1286
2020
Q3 		$97K Buy
+10,329
New +$112K ﹤0.01% 1540
2019
Q4 		– Sell
-20,351
Closed -$184K – 1583
2019
Q3 		$184K Buy
+20,351
New +$228K 0.01% 1173
2015
Q3 		– Sell
-11,400
Closed -$126K – 170
2015
Q2 		$126K Buy
+11,400
New +$147K 0.06% 149

Other funds holding SGMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

HRT Financial's SGMO Position: Q3 2025 in Review

HRT Financial sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q3 2025, closing a stake of 205,170 shares — an estimated $111K sold.

HRT Financial first reported a position in SGMO in Q2 2015 and held it in 15 quarters. The position peaked at $1M in Q2 2021. 112 funds tracked by Wall St. Rank hold SGMO as of Q3 2025.

  • HRT Financial reported no remaining SANGAMO THERAPEUTICS INC position as of Q3 2025 after selling out during the quarter.
  • HRT Financial sold 205,170 SANGAMO THERAPEUTICS INC shares in Q3 2025, an estimated $111K.
  • HRT Financial first reported a position in SANGAMO THERAPEUTICS INC in Q2 2015 and held it in 15 quarters.
  • HRT Financial's SANGAMO THERAPEUTICS INC position peaked at $1M in Q2 2021.
  • 112 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q3 2025.

Based on HRT Financial's 13F filing for Q3 2025, filed 14 Nov 2025.